Multiplex Assay Kit for Chemokine (C-X-C Motif) Ligand 2 (CXCL2) ,etc. by FLIA (Flow Luminescence Immunoassay)

GROb; SCYB2; MIP2; GRO2; MIP2a; MGSAb; CINC2a; HSF; Macrophage inflammatory protein 2-alpha; Hematopoietic synergistic factor; Growth Regulated Oncogene Beta

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Chemokine (C-X-C Motif) Ligand 2 (CXCL2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Chemokine (C-X-C Motif) Ligand 2 (CXCL2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Chemokine (C-X-C Motif) Ligand 2 (CXCL2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Chemokine (C-X-C Motif) Ligand 2 (CXCL2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-98 85
EDTA plasma(n=5) 86-101 95
heparin plasma(n=5) 93-105 97

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Chemokine (C-X-C Motif) Ligand 2 (CXCL2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Chemokine (C-X-C Motif) Ligand 2 (CXCL2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Chemokine (C-X-C Motif) Ligand 2 (CXCL2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 79-103% 85-93% 95-104% 81-89%
EDTA plasma(n=5) 85-101% 93-101% 81-101% 92-101%
heparin plasma(n=5) 93-104% 84-103% 80-105% 93-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CXCL2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
FEBS Journal Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclear factor kappa B PubMed: 19120450
PLoS One. HIF-1α Is Essential for Effective PMN Bacterial Killing, Antimicrobial Peptide Production and Apoptosis in Pseudomonas aeruginosa Keratitis Plos: Source
Physiol Genomics. Identification of human exercise-induced myokines using secretome analysis Pubmed:24520153
Diabetes Protein Inhibitor of Activated STAT 1 (PIAS1) Protects Against Obesity-Induced Insulin Resistance by Inhibiting Inflammation Cascade in Adipose Tissue PubMed: 26324179
Respiration Bubble CPAP support after discontinuation of mechanical ventilation protects rat lungs with ventilator-induced lung injury Pubmed:26800273
Scientific Reports The Transcriptional Foundations of Sp110-mediated Macrophage (RAW264. 7) Resistance to Mycobacterium tuberculosis H37Ra Pubmed:26912204
Cellular Physiology and Biochemistry Dexmedetomidine Alleviates HyperoxiaInduced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation pubmed:28873369
Medicine (Baltimore) Rapid detection of urinary soluble intercellular adhesion molecule-1 for determination of lupus nephritis activity Pubmed:29953010
Hepatology Integrated Omics Reveals Tollip as an Aggravator and Therapeutic Target for Hepatic Ischemia‐Reperfusion Injury in Mice Pubmed: 31077413
Molecular Medicine Reports IL‑17A promotes CXCR2‑dependent angiogenesis in a mouse model of liver cancer Pubmed: 31173199
Anticancer Research The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer Pubmed: 31810929
Lab Invest Extracellular cold-inducible RNA-binding protein regulates neutrophil extracellular trap formation and tissue damage in acute pancreatitis Pubmed: 32709888
SCIENCE OF THE TOTAL ENVIRONMENT Assessment of acute toxicological effects of molybdenum (IV) disulfide nano-and microparticles after single intratracheal administration in rats Pubmed: 32629262
Autophagy Vitamin D3 and carbamazepine protect against Clostridioides difficile infection in mice by restoring macrophage lysosome acidification Pubmed:34989311
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB603Hu01 Active Chemokine (C-X-C Motif) Ligand 2 (CXCL2) Cell culture; Activity Assays.
RPB603Hu01 Recombinant Chemokine (C-X-C Motif) Ligand 2 (CXCL2) Positive Control; Immunogen; SDS-PAGE; WB.
RPB603Hu02 Recombinant Chemokine (C-X-C Motif) Ligand 2 (CXCL2) Positive Control; Immunogen; SDS-PAGE; WB.
RPB603Hu03 Recombinant Chemokine (C-X-C Motif) Ligand 2 (CXCL2) Positive Control; Immunogen; SDS-PAGE; WB.
PAB603Hu01 Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 2 (CXCL2) WB; IHC; ICC; IP.
PAB603Hu02 Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 2 (CXCL2) WB,IHC
PAB603Hu03 Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 2 (CXCL2) WB; IHC; ICC; IP.
LAB603Hu71 Biotin-Linked Polyclonal Antibody to Chemokine (C-X-C Motif) Ligand 2 (CXCL2) WB; IHC; ICC.
MAB603Hu22 Monoclonal Antibody to Chemokine (C-X-C Motif) Ligand 2 (CXCL2) WB; IHC; ICC; IP.
SEB603Hu ELISA Kit for Chemokine (C-X-C Motif) Ligand 2 (CXCL2) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB603Hu CLIA Kit for Chemokine (C-X-C Motif) Ligand 2 (CXCL2) Chemiluminescent immunoassay for Antigen Detection.
LMB603Hu Multiplex Assay Kit for Chemokine (C-X-C Motif) Ligand 2 (CXCL2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.